HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail aims to shrink head and neck tumors before surgery
Disease control Recruiting nowThis phase 2 trial tests a new combination of drugs—imaxitinib, chemotherapy, and immunotherapy—given before surgery for advanced head and neck cancer. The goal is to see if this approach can shrink tumors more effectively, making surgery easier or possible for patients whose can…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 23, 2026 22:17 UTC
-
New shot SH009 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called SH009 in people with advanced solid tumors (like liver, lung, breast, or stomach cancer) that have not responded to standard treatments. The main goals are to see if the drug shrinks tumors and to check its safety. About 150 adults w…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New combo therapy aims to shrink head and neck tumors
Disease control Recruiting nowThis phase 2 study tests whether adding the experimental drug VS-101 to standard chemoradiotherapy helps shrink tumors in 30 adults with head and neck cancer. Participants are randomly assigned to receive VS-101 plus chemoradiation or chemoradiation alone. The main goal is to see…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Could 5 radiation sessions be as good as 30 for skin cancer?
Disease control Recruiting nowThis study tests whether a shorter, more intense type of radiation (stereotactic radiotherapy given in 5 sessions) works as well as the standard longer course (20-30 sessions) for treating skin cancer that has spread to the parotid gland in the head and neck. About 90 adults who …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC